Follow
Steve Clifford
Steve Clifford
Professor of Paediatric Oncology & Director, Newcastle University Centre for Cancer
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
PH Maxwell, MS Wiesener, GW Chang, SC Clifford, EC Vaux, ...
Nature 399 (6733), 271-275, 1999
63251999
Molecular subgroups of medulloblastoma: the current consensus
MD Taylor, PA Northcott, A Korshunov, M Remke, YJ Cho, SC Clifford, ...
Acta neuropathologica 123, 465-472, 2012
21482012
Medulloblastoma comprises four distinct molecular variants
PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ...
Journal of clinical oncology 29 (11), 1408-1414, 2011
15782011
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman, N Masson, DR Mole, P Jaakkola, GW Chang, SC Clifford, ...
Journal of Biological Chemistry 275 (33), 25733-25741, 2000
14192000
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ...
Acta neuropathologica 123, 473-484, 2012
11702012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ...
Nature 488 (7409), 49-56, 2012
9972012
Dissecting the genomic complexity underlying medulloblastoma
DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Nature 488 (7409), 100-105, 2012
9822012
Subtypes of medulloblastoma have distinct developmental origins
P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ...
Nature 468 (7327), 1095-1099, 2010
9602010
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
8412008
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121, 381-396, 2011
6632011
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ...
Acta Neuropathologica, 2016
6552016
Medulloblastoma
PA Northcott, GW Robinson, CP Kratz, DJ Mabbott, SL Pomeroy, ...
Nature reviews Disease primers 5 (1), 11, 2019
5762019
β-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison, OE Onilude, JC Lindsey, ME Lusher, CL Weston, RE Taylor, ...
Journal of Clinical Oncology 23 (31), 7951-7957, 2005
5422005
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ...
Journal of Clinical Oncology 31 (23), 2927-2935, 2013
5392013
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
EC Schwalbe, JC Lindsey, S Nakjang, S Crosier, AJ Smith, D Hicks, ...
The Lancet Oncology 18 (7), 958-971, 2017
5312017
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ...
Human molecular genetics 10 (10), 1029-1038, 2001
4652001
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ...
Journal of clinical oncology 30 (26), 3187-3193, 2012
3872012
Cytogenetic prognostication within medulloblastoma subgroups
DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Journal of clinical oncology 32 (9), 886-896, 2014
3722014
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables
DW Ellison, M Kocak, J Dalton, H Megahed, ME Lusher, SL Ryan, W Zhao, ...
Journal of clinical oncology 29 (11), 1400-1407, 2011
3722011
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
UK Tyne
Cell Cycle 5 (22), 2666-2670, 2006
3592006
The system can't perform the operation now. Try again later.
Articles 1–20